FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2045790951> ?p ?o ?g. }

• W2045790951 endingPage "1027" @default.
• W2045790951 startingPage "1016" @default.
• W2045790951 abstract "Aim This study evaluated the efficacy and safety of canagliflozin, a sodium glucose co-transporter 2 inhibitor, in patients with type 2 diabetes mellitus (T2DM) and within a subset of Stage 3 chronic kidney disease (CKD; estimated glomerular filtration rate [eGFR] ≥30 and <50 ml/min/1.73 m2). Methods In this 52-week, randomized, double-blind, placebo-controlled study, patients (N = 269; mean eGFR, 39.4 ml/min/1.73 m2) received canagliflozin 100 or 300 mg and placebo once daily. Efficacy endpoints included changes in glycated haemoglobin (HbA1c), fasting plasma glucose (FPG), body weight and systolic blood pressure (BP); adverse events (AEs) were also recorded. Results At week 52, canagliflozin 100 and 300 mg reduced HbA1c compared with placebo (−0.19, −0.33 and 0.07%, respectively); placebo-subtracted differences (95% confidence interval) were −0.27% (−0.53, 0.001) and −0.41% (−0.68, −0.14). Canagliflozin also lowered FPG, body weight and BP versus placebo. Overall AE incidence was 85.6, 80.9, and 86.7% with canagliflozin 100 and 300 mg and placebo, respectively. Osmotic diuresis–related AEs were more common with both canagliflozin doses, and incidences of urinary tract infections and volume depletion–related AEs were higher with canagliflozin 300 mg versus placebo. Decreases in eGFR (−2.1, −4.0 and −1.6 ml/min/1.73 m2) were seen with canagliflozin 100 and 300 mg compared with placebo. Canagliflozin 100 and 300 mg provided median percent reductions in urine albumin to creatinine ratio versus placebo (−16.4, −28.0 and 19.7%). Conclusions Canagliflozin improved glycaemic control and was generally well tolerated in patients with T2DM and within a subset of Stage 3 CKD over 52 weeks." @default.
• W2045790951 created "2016-06-24" @default.
• W2045790951 creator A5002396838 @default.
• W2045790951 creator A5003090099 @default.
• W2045790951 creator A5009182471 @default.
• W2045790951 creator A5027581435 @default.
• W2045790951 creator A5031542137 @default.
• W2045790951 creator A5037524890 @default.
• W2045790951 creator A5049090208 @default.
• W2045790951 creator A5061317385 @default.
• W2045790951 creator A5063511872 @default.
• W2045790951 creator A5075546644 @default.
• W2045790951 creator A5076983296 @default.
• W2045790951 creator A5083951620 @default.
• W2045790951 date "2014-07-22" @default.
• W2045790951 modified "2023-10-14" @default.
• W2045790951 title "Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes mellitus and chronic kidney disease" @default.
• W2045790951 cites W1967064223 @default.
• W2045790951 cites W1968145432 @default.
• W2045790951 cites W1973240292 @default.
• W2045790951 cites W1982905493 @default.
• W2045790951 cites W1986085856 @default.
• W2045790951 cites W1987553321 @default.
• W2045790951 cites W1994832750 @default.
• W2045790951 cites W1997018189 @default.
• W2045790951 cites W2017268330 @default.
• W2045790951 cites W2021988691 @default.
• W2045790951 cites W2031333151 @default.
• W2045790951 cites W2036592965 @default.
• W2045790951 cites W2038270027 @default.
• W2045790951 cites W2068171948 @default.
• W2045790951 cites W2072953734 @default.
• W2045790951 cites W2074989651 @default.
• W2045790951 cites W2077038286 @default.
• W2045790951 cites W2081510795 @default.
• W2045790951 cites W2082511677 @default.
• W2045790951 cites W2111875582 @default.
• W2045790951 cites W2114250030 @default.
• W2045790951 cites W2120919346 @default.
• W2045790951 cites W2122808146 @default.
• W2045790951 cites W2130570549 @default.
• W2045790951 cites W2162934281 @default.
• W2045790951 cites W2168926920 @default.
• W2045790951 cites W2172193326 @default.
• W2045790951 doi "https://doi.org/10.1111/dom.12348" @default.
• W2045790951 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24965700" @default.
• W2045790951 hasPublicationYear "2014" @default.
• W2045790951 type Work @default.
• W2045790951 sameAs 2045790951 @default.
• W2045790951 citedByCount "213" @default.
• W2045790951 countsByYear W20457909512014 @default.
• W2045790951 countsByYear W20457909512015 @default.
• W2045790951 countsByYear W20457909512016 @default.
• W2045790951 countsByYear W20457909512017 @default.
• W2045790951 countsByYear W20457909512018 @default.
• W2045790951 countsByYear W20457909512019 @default.
• W2045790951 countsByYear W20457909512020 @default.
• W2045790951 countsByYear W20457909512021 @default.
• W2045790951 countsByYear W20457909512022 @default.
• W2045790951 countsByYear W20457909512023 @default.
• W2045790951 crossrefType "journal-article" @default.
• W2045790951 hasAuthorship W2045790951A5002396838 @default.
• W2045790951 hasAuthorship W2045790951A5003090099 @default.
• W2045790951 hasAuthorship W2045790951A5009182471 @default.
• W2045790951 hasAuthorship W2045790951A5027581435 @default.
• W2045790951 hasAuthorship W2045790951A5031542137 @default.
• W2045790951 hasAuthorship W2045790951A5037524890 @default.
• W2045790951 hasAuthorship W2045790951A5049090208 @default.
• W2045790951 hasAuthorship W2045790951A5061317385 @default.
• W2045790951 hasAuthorship W2045790951A5063511872 @default.
• W2045790951 hasAuthorship W2045790951A5075546644 @default.
• W2045790951 hasAuthorship W2045790951A5076983296 @default.
• W2045790951 hasAuthorship W2045790951A5083951620 @default.
• W2045790951 hasConcept C126322002 @default.
• W2045790951 hasConcept C126894567 @default.
• W2045790951 hasConcept C134018914 @default.
• W2045790951 hasConcept C142724271 @default.
• W2045790951 hasConcept C159641895 @default.
• W2045790951 hasConcept C204787440 @default.
• W2045790951 hasConcept C27081682 @default.
• W2045790951 hasConcept C2775887513 @default.
• W2045790951 hasConcept C2777180221 @default.
• W2045790951 hasConcept C2777451236 @default.
• W2045790951 hasConcept C2778653478 @default.
• W2045790951 hasConcept C555293320 @default.
• W2045790951 hasConcept C71924100 @default.
• W2045790951 hasConcept C90924648 @default.
• W2045790951 hasConceptScore W2045790951C126322002 @default.
• W2045790951 hasConceptScore W2045790951C126894567 @default.
• W2045790951 hasConceptScore W2045790951C134018914 @default.
• W2045790951 hasConceptScore W2045790951C142724271 @default.
• W2045790951 hasConceptScore W2045790951C159641895 @default.
• W2045790951 hasConceptScore W2045790951C204787440 @default.
• W2045790951 hasConceptScore W2045790951C27081682 @default.
• W2045790951 hasConceptScore W2045790951C2775887513 @default.
• W2045790951 hasConceptScore W2045790951C2777180221 @default.
• W2045790951 hasConceptScore W2045790951C2777451236 @default.
• W2045790951 hasConceptScore W2045790951C2778653478 @default.

• next